Matthew Norkunas - 15 Oct 2024 Form 4 Insider Report for Generation Bio Co. (GBIO)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Shawna-Gay White, Attorney-in-Fact
Issuer symbol
GBIO
Transactions as of
15 Oct 2024
Net transactions value
-$2,381
Form type
4
Filing time
17 Oct 2024, 16:05:12 UTC
Previous filing
17 Jul 2024
Next filing
10 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GBIO Common Stock Options Exercise +1,674 +3% 56,659 15 Oct 2024 Direct F1
transaction GBIO Common Stock Tax liability $1,191 -492 -0.87% $2.42 56,167 15 Oct 2024 Direct
transaction GBIO Common Stock Options Exercise +1,673 +3% 57,840 15 Oct 2024 Direct F1
transaction GBIO Common Stock Tax liability $1,191 -492 -0.85% $2.42 57,348 15 Oct 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GBIO Restricted Stock Units Options Exercise $0 -1,674 -10% $0.000000 15,059 15 Oct 2024 Common Stock 1,674 Direct F1, F2
transaction GBIO Restricted Stock Units Options Exercise $0 -1,673 -50% $0.000000 1,673 15 Oct 2024 Common Stock 1,673 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive one share of the company's common stock.
F2 On January 20, 2023, the reporting person was granted 26,775 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter.
F3 On January 20, 2023, the reporting person was granted 13,388 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2023 and the remaining shares vesting in equal quarterly installments thereafter.